Reuters logo
BRIEF-Cosmo announces details of successful phase III clinical trials of LuMeBlue
2016年11月29日 / 早上6点11分 / 10 个月前

BRIEF-Cosmo announces details of successful phase III clinical trials of LuMeBlue

Nov 29 (Reuters) - Cosmo Pharmaceuticals NV :

* Announces details of successful phase III clinical trials of LuMeBlue which will be presented at its research and development day

* LuMeBlue attained primary endpoint identifying 17.71 pct more patients with adenomas or carcinomas than HDWL (p value 0.009; relative risk-rr-1.177) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below